Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Seqirus
Manufacturing
CSL Seqirus picks up its 5th bird-flu-related BARDA award
With a $121.4 million award, the vaccine maker will make enough adjuvant for 40 million vaccine doses.
Zoey Becker
Sep 26, 2024 3:50pm
Driving flu vaccine uptake in the post-pandemic era
Aug 30, 2024 8:00am
Europe taps CSL Seqirus to produce bird flu vaccines
Jun 11, 2024 4:20pm
UK enlists CSL Seqirus for flu pandemic vaccine preparedness
Sep 26, 2023 10:55am
Japan awarded $115M to Arcturus JV to boost mRNA manufacturing
Aug 14, 2023 11:58am
New CEO Paul McKenzie plots CSL's course for growth
Apr 3, 2023 9:25am
